Please login to the form below

Not currently logged in
Email:
Password:

JK Associates

This page shows the latest JK Associates news and features for those working in and with pharma, biotech and healthcare.

Fishawack acquires brand communications agency Healthcircle

Fishawack acquires brand communications agency Healthcircle

Fishawack also operates under four other brands, including Medical communications groups Fishawack Communications and Fishawack Facilitate, specialist publication and scientific services group Fishawack Indicia and US-based JK Associates.

Latest news

  • Fishawack undergoes management buyout Fishawack undergoes management buyout

    In recent years the agency's acquisitions have included UK med comms agency Facilitate, US group JK Associates and Swiss agency  Archimed..

  • Fishawack opens San Francisco office Fishawack opens San Francisco office

    Oliver Dennis, CEO of Fishawack, said: “ Following the expansions of our east coast US team earlier this year when JK Associates joined the Group, the next logical step was to invest

  • Archimed drug safety specialists rebrand Archimed drug safety specialists rebrand

    It made its second US acquisition, JK Associates, in April 2014.

  • Fishawack buys JK Associates

    Fishawack buys JK Associates. Healthcare comms agency adds US-based group to portfolio. ... JK Associates president and CEO John (Zeke) Czekanski and COO Kevin Pawley will continue managing their company's day-to-day operations, and will join the

More from news
Approximately 2 fully matching, plus 3 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
W2O Group

W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...

Latest intelligence

Theresa Heggie
Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe
Theresa Heggie talks about the biotech’s 16-year path to market, and the promise of its ‘gene silencing’ medicines...
patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...

Infographics